• Posted On Sunday, February 7, 2021 by Evan Lamolinara

    Pharma Q4 2020 (1)

    SalesLeads announced today the Q4 2020 results for the new planned capital project spending report for the Pharmaceutical and BioTech industry. The Firm tracks North American planned industrial capital project activity including facility expansions, new plant construction and significant equipment modernization project. Research confirms 108 new projects in the Pharmaceutical sector.

    Planned industrial project activity within the sector is up 15% YTD over the previous year.

    The following are selected highlights on new Pharmaceutical industry construction news.

     

    Pharmaceutical - By Project Type

                Manufacturing/Processing Facilities - 82 New Projects

                Laboratory Facilities - 32 New Projects

                Distribution and Industrial Warehouse - 17 New Projects

               

    Pharmaceutical - By Project Scope/Activity

                New Construction - 34 New Projects

                Expansion - 35 New Projects

                Renovations/Equipment Upgrades - 51 New Projects

                Plant Closing - 2 New Projects

     

    Pharmaceutical - By Project Location (Top 5 States)

                California - 15

                New York - 10

                Indiana - 8

                Massachusetts - 7

                North Carolina - 7

     

    Largest Planned Project

    During the 4th quarter of 2020, our research team identified 9 new Pharmaceutical facility construction projects with an estimated value of $100 million or more.

    The largest project is owned by Hoffmann-La Roche, Ltd., who is planning to invest $500 million for the expansion, renovation, and equipment upgrades at their processing and laboratory facility in MISSISSAUGA, ON.

     

    Top 5 Tracked Pharmaceutical Projects

    INDIANA:

    Pharmaceutical company is planning to invest $300 million for the construction of a processing and office facility in INDIANAPOLIS, IN. They have recently received approval for the project. Construction is expected to start in Summer 2021. They will consolidate operations upon completion in 2023.

    IOWA:

    Biotechnology company is planning to invest $100 million for the renovation and equipment upgrades on a processing facility in CLINTON, IA. They have recently received approval for the project.

    MASSACHUSETTS:

    Biotechnology company is planning to invest $115 million for the construction of a 79,000 sf processing and office facility at 110 Campus Drive in MARLBOROUGH, MA. They have recently received approval for the project.

    NORTH CAROLINA:

    Biopharmaceutical company is planning to invest $150 million for the construction of a 140,000 sf processing facility in RESEARCH TRIANGLE PARK, NC. Completion is slated for early 2022.

    NEBRASKA:

    Medical technology company is planning to invest $150 million for the renovation and equipment upgrades of their manufacturing facility in COLUMBUS, NE. They have recently received approval for the project.

     

    Since 1959, SalesLeads, based out of Jacksonville, FL has been providing Industrial Project Reports on companies that are planning significant capital investments in their industrial facilities throughout North America. Our professional research team identifies new construction, expansion, relocation, major renovation, equipment upgrades, and plant closing project opportunities so that our clients can focus sales and marketing resources on the target accounts that have an impending need for their products, services, and indirect materials.

    Each month, our team provides hundreds of industrial reports within a variety of industries, including:


    Comment